Report Summary August 19, 1994
 Current Issue Cover Photo

Prozac
Are drugs for treating mental illness being used too freely?
By Mary H. Cooper

Officially, Prozac has been approved only for treating two serious mental diseases: clinical depression and obsessive-compulsive disorder. But millions of people in the U.S. are turning to the distinctive green-and-white capsules just to pull themselves out of the dumps. They've helped make Prozac one of the world's most widely prescribed medications. Prozac's extensive use has sparked an intense debate. . . .

Read the Full Report (Subscription Required)



Spotlight

Prozac has received final approval from the Food and Drug Administration (FDA) for the treatment of two serious illnesses and preliminary approval for a third:

Depression: The FDA first approved Prozac for treating clinical depression, a condition far more serious than the “blues” that everyone experiences from time to time or the temporary grief that follows a major loss. This severe form of depression strikes an estimated 15 million Americans each year and will affect more than 8 percent of the population during their lifetimes. A milder form of depression is called dysthymia. The American Psychiatric Association defines severe depression as the almost constant presence of five or more of the following symptoms for at least two weeks:

-- depressed mood most of the day, nearly every day;

-- loss of interest or pleasure in previously enjoyed activities;

-- significant changes in weight or appetite;

-- sleep disturbances (oversleeping, waking up early, trouble falling asleep);

-- feelings of guilt, helplessness or lack of self-worth;

-- decreased ability to concentrate;

-- fatigue or loss of energy;

-- anxiety, restlessness or slowed activity;

-- hopelessness or thoughts about death or suicide.

Obsessive-Compulsive Disorder: This condition was recently approved by the FDA for treatment by Prozac. OCD, as it is known, is characterized by recurrent, unpleasant and unwanted thoughts (obsessions), or repetitive, ritualistic behaviors that a person feels driven to perform (compulsions). OCD affects about 4 million Americans, or 2 percent of the population. A person with OCD may experience obsessions or compulsions alone or in combination. Patients typically recognize the irrationality of their thoughts or behaviors but are unable to control them. Typical obsessions include:

-- fear of dirt and contamination;

-- fear of acting on violent or aggressive impulses;

-- feeling overly responsible for others' safety;

-- inordinate concern with order, arrangement or symmetry.

Typical compulsions include:

-- washing, cleaning, counting, arranging, checking, saving and repeating.

Bulimia: In April, an FDA panel recommended approval of Prozac for treatment of bulimia nervosa, a chronic eating disorder. Uncommon in men, bulimia may affect as many as 2.8 percent of American women during their lifetimes, mainly between the ages of 18 and 35. Bulimia is accompanied by some or all of the following symptoms:

-- recurrent episodes of binge eating;

-- feelings of lack of control;

-- self-induced vomiting;

-- use of laxatives or diuretics;

-- strict dieting or fasting or vigorous exercise to prevent weight gain;

-- an average of at least two binge-eating episodes a week for at least three months;

Sources: Eli Lilly and Co.; U.S. Public Health Service


Document Citation
Cooper, M. H. (1994, August 19). Prozac. CQ Researcher, 4, 721-744. Retrieved from http://library.cqpress.com/cqresearcher/
Document ID: cqresrre1994081900
Document URL: http://library.cqpress.com/cqresearcher/cqresrre1994081900


Issue Tracker for Related Reports
Mental Health
May 10, 2013  Mental Health Policy
Aug. 03, 2012  Treating ADHD
Jun. 01, 2012  Traumatic Brain Injury
Jun. 26, 2009  Treating Depression
Feb. 13, 2004  Youth Suicide
Feb. 06, 2004  Mental Illness Medication Debate
Mar. 29, 2002  Mental Health Insurance
Feb. 08, 2002  Treating Anxiety
Jul. 16, 1999  Childhood Depression
Jun. 18, 1999  Boys' Emotional Needs
Sep. 12, 1997  Mental Health Policy
Aug. 19, 1994  Prozac
Aug. 06, 1993  Mental Illness
Oct. 09, 1992  Depression
Jun. 14, 1991  Teenage Suicide
Jul. 08, 1988  Biology Invades Psychology
Feb. 13, 1987  The Mentally Ill
Aug. 20, 1982  Mental Health Care Reappraisal
Jun. 12, 1981  Youth Suicide
Sep. 21, 1979  Mental Health Care
Sep. 15, 1978  Brain Research
Jul. 05, 1974  Psychomedicine
Aug. 08, 1973  Emotionally Disturbed Children
Dec. 27, 1972  Mental Depression
Mar. 24, 1972  Schizophrenia: Medical Enigma
Apr. 21, 1971  Approaches to Death
Mar. 03, 1971  Encounter Groups
Nov. 25, 1970  Psychological Counseling of Students
Feb. 19, 1969  Future of Psychiatry
Feb. 02, 1966  New Approaches to Mental Illness
Jan. 22, 1964  Insanity as a Defense
Sep. 25, 1963  Anatomy of Suicide
Nov. 20, 1957  Drugs and Mental Health
Apr. 23, 1954  Mental Health Programs
Jul. 09, 1948  Mental Health

Browse Related Topics
Mental Health
Pharmaceuticals